atovaquone

Generic: atovaquone

Labeler: bionpharma inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name atovaquone
Generic Name atovaquone
Labeler bionpharma inc.
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

atovaquone 750 mg/5mL

Manufacturer
Bionpharma Inc.

Identifiers & Regulatory

Product NDC 69452-252
Product ID 69452-252_4523911f-9d9c-4b0c-e063-6394a90ac76d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212918
Listing Expiration 2026-12-31
Marketing Start 2021-06-01

Pharmacologic Class

Established (EPC)
antimalarial [epc] antiprotozoal [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69452252
Hyphenated Format 69452-252

Supplemental Identifiers

RxCUI
308429
UPC
0369452252871
UNII
Y883P1Z2LT
NUI
N0000175482 N0000175485

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name atovaquone (source: ndc)
Generic Name atovaquone (source: ndc)
Application Number ANDA212918 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 750 mg/5mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (69452-252-87) / 210 mL in 1 BOTTLE
source: ndc

Packages (1)

Ingredients (1)

atovaquone (750 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4523911f-9d9c-4b0c-e063-6394a90ac76d", "openfda": {"nui": ["N0000175482", "N0000175485"], "upc": ["0369452252871"], "unii": ["Y883P1Z2LT"], "rxcui": ["308429"], "spl_set_id": ["bff4f4fc-6307-f414-e053-2a95a90ac0de"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["Bionpharma Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (69452-252-87)  / 210 mL in 1 BOTTLE", "package_ndc": "69452-252-87", "marketing_start_date": "20210601"}], "brand_name": "Atovaquone", "product_id": "69452-252_4523911f-9d9c-4b0c-e063-6394a90ac76d", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "69452-252", "generic_name": "Atovaquone", "labeler_name": "Bionpharma Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atovaquone", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "ANDA212918", "marketing_category": "ANDA", "marketing_start_date": "20210601", "listing_expiration_date": "20261231"}